This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 5: Kidney On October 26, the fifth module of the Dia-Month Club was held on the topic of kidneys. Our expert, PD Dr. Michael Mayr (University Hospital Basel), explained the practical guardrails… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 6: Consequential diseases On November 18, the sixth module of the Dia-Month Club was held on the topic of secondary diseases of type 2 diabetes. Our expert, Dr. Thanh-Truc Ngô Bá (St. Claraspital,… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 7: Digital Tools On December 9, the seventh and final module of the 2021 Dia-Month Club was held on the topic of digital tools. Our expert, Prof. Roger Lehmann (University Hospital Zurich), explained… CME-Test
View Post 5 min This content is machine translated Type 2 diabetes mellitus SGLT-2 inhibitor has cardioprotective effect in different risk groups Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular complications [1]. However, SGLT-2 inhibitors may prevent cardiovascular events in addition to lowering blood glucose levels [2, 3]. For…
View Post 4 min This content is machine translated GLP-1 receptor agonists (GLP-1-RA) Type 2 diabetics benefit from dulaglutide in several ways The ADA/EASD guidelines recommend individualized therapy choices for type 2 diabetics. GLP-1 receptor agonists not only improve glycemic control, but also support weight loss, reduce the risk of cardiovascular disease,…
View Post 5 min This content is machine translated Corona pandemic Diabetes patients with COVID-19: current expert assessment. Poorly controlled diabetes is a risk factor for severe COVID-19 progression. Therefore, especially during the corona pandemic, the best possible blood glucose control is crucial. However, it has been shown…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 10 min This content is machine translated Chronic inflammatory bowel disease (CED) Modern “State-of-the-Art” Pharmacotherapy – an Update Modern approaches to the treatment of inflammatory bowel disease (IBD) are based on the motto “treat-to-target”, whereby in addition to symptom relief and induction of disease remission, the aim nowadays… CME-Test
View Post 3 min This content is machine translated Diabetes Management Type 1 diabetics benefit from additive oral therapy Type 1 diabetics with obesity in whom insulin therapy alone is insufficient for glycemic control may additionally benefit from oral treatment with an SGLT2 inhibitor. Recent study results show good…
View Post 4 min This content is machine translated Diabetes Cases Intensification of the treatment of type 2 diabetes mellitus In a 63-year-old patient, although glucose metabolic control is quite good, there is still potential for optimizing diabetes management. Thus, with a change in therapy, his pre-existing cardiovascular conditions can…
View Post 4 min This content is machine translated SGLT-2 inhibitors and GLP-1-RA How they can protect against diabetic sequelae In recent years, numerous new glucose-lowering agents have been developed. SGLT-2 inhibitors and GLP-1 receptor agonists have demonstrated cardiovascular and nephroprotective effects in large clinical endpoint studies. The variety of…
